eISSN 2508-3589
pISSN 2508-1926

Table. 4.

Table. 4.

Mean changes in BCVA, CMT, and IOP according to kind of injection (non-perfusion type)

Feature Group A (n = 10) Group B (n = 13) Group C (n = 38) p-value * Post-hoc test
Mean change in BCVA (logMAR) 0.439 ± 0.17 0.690 ± 0.16 0.136 ± 0.05 0.012 0.320, 0.005, 0.028§
Mean change in CMT (μm) 437.2 ± 54.8 412.5 ± 83.4 264.4 ± 57.0 0.025 0.642, 0.142, 0.008§
Mean change in IOP (mmHg) -2.3 ± 0.8 -0.6 ± 0.7 -0.7 ± 0.4 0.186 0.150, 0.922, 0.072§

Values are presented as mean ± standard deviation. Group A refers to the dexamethasone implant injection arm. Group B refers to the bevacizumab to dexamethasone implant injection arm. Group C refers to the bevacizumab injection arm.

BCVA = best corrected visual acuity; logMAR = logarithm of minimal angle of resolution; CMT = central macular thickness; IOP = intraocular pressure.

*
p-value for three-group comparison by the Kruskal-Wallis test; Comparison between Groups A and B; Comparison between Groups B and C; §Comparison between Groups A and C.

J Retin 2020;5:135-42 https://doi.org/10.21561/jor.2020.5.2.135
© 2020 J Retin